Ignite Creation Date:
2024-05-06 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06228937
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-19
Brief Title:
Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Overview
Official Title:
Typing of Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis a Prospective Observational Study
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LymphFM
Brief Summary:
Lymphedema is a chronic and progressive disease of the lymphatic vessels which affects about 300 million people worldwide Patients may experience recurrent soft tissue infection of the limb affected by lymphedema in terms of erysipelas lymphangitis or cellulitis No previous study has ever investigated the possible role of the gut microbiota in the genesis of acute infectiousinflammatory episodes in these patients Our hypothesis is that lymphedema patients with recurrent soft tissue infections are characterized by pro-inflammatory changes in the microbiota
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None